Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 3 31Phase 1 14Phase 1/2 7Phase 4 5Phase NA 3

Status

Completed 4Terminated 1

Sponsor Class

OTHER 7INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Neoplasm Metastasis 2Skin Diseases 1Neoplasms 1Breast Diseases 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × exemestane × Clear all
NCT03220178 2022-01-06

PRECYCLE

Palleos Healthcare GmbH

Phase 4 Terminated
532 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01176916 2021-10-27

AromasinĀ® Interventional Study Of Early Invasive Breast Cancer Patients In China

Pfizer

Phase 4 Completed
564 enrolled 13 charts
Breast

Breast Neoplasms

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed
52 enrolled 16 charts
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

NCT02248571 2017-11-13

IMPROVE

iOMEDICO AG

Phase 4 Completed
85 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00649090 2008-09-29

A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Pfizer

Phase 4 Completed
1,549 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔